Loading clinical trials...
Loading clinical trials...
Notwithstanding major improvements in treatment modalities, the prognosis of patients with glioblastoma is poor. Hypofractionated radiation therapy as an alternative of the standard 6-week regimen cou...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Instituto do Cancer do Estado de São Paulo
NCT06039709 · Recurrent Glioblastoma, Glioblastoma Multiforme, and more
NCT06814496 · Melanoma, Medullary Thyroid Cancer, and more
NCT06466031 · Glioblastoma Multiforme
NCT03596086 · Glioblastoma Multiforme, Astrocytoma, Grade III
NCT05839379 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and more
Instituto do Cancer do Estado de São Paulo (ICESP) - FMUSP
São Paulo, São Paulo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions